Thrombosis in a patient with combined homozygosity for the factor V Leiden mutation and a mutation in the 3′-untranslated region of the prothrombin gene

被引:18
|
作者
Wulf, GM
Van Deerlin, VMD
Leonard, DGB
Bauer, KA
机构
[1] Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02132 USA
[2] Univ Penn, Med Ctr, Dept Pathol & Lab Med, Philadelphia, PA USA
关键词
thrombosis; mutation; factor V Leiden; prothrombin gene mutation;
D O I
10.1097/00001721-199903000-00008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The factor V Leiden mutation and a guanine-to-adenine mutation at nucleotide 20210 in the 3'-untranslated region of the prothrombin gene are the most prevalent genetic defects in patients with deep venous thrombosis. Heterozygosity for the factor V Leiden and the prothrombin gene mutations is found in approximately 20 and 6% of unselected patients with deep venous thrombosis, respectively, whereas the prevalences of the two mutations in the general Caucasian population are approximately 6 and 2%, respectively. We evaluated an 18-year-old man presenting with a spontaneous episode of superficial venous thrombosis for the presence of an inherited thrombotic disorder. After excluding deficiencies of antithrombin, protein C, and protein S, genomic DNA from the patient was tested for the presence of the factor V Leiden and prothrombin gene mutations. Consanguinity was not present in the family. Genotyping demonstrated that the patient was homozygous for the factor V Leiden and prothrombin gene mutations. The likelihood of identifying an individual in the general population who is homozygous for both mutations similar to our patient is estimated to be less than 1 in 10 million. (C) 1999 Lippincote Williams & Wilkins.
引用
收藏
页码:107 / 110
页数:4
相关论文
共 50 条
  • [21] A case of hypereosinophilic syndrome associated with factor V Leiden mutation and thrombosis
    Gümrük, F
    Gürgey, A
    Altay, C
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 (01) : 208 - 209
  • [22] Hyperhomocysteinemia and other newly recognized inherited coagulation disorders (factor V Leiden and prothrombin gene mutation) in patients with idiopathic cerebral vein thrombosis
    Ventura, P
    Cobelli, M
    Marietta, M
    Panini, R
    Rosa, MC
    Salvioli, G
    CEREBROVASCULAR DISEASES, 2004, 17 (2-3) : 153 - 159
  • [23] Factor V G1691A (Leiden) and prothrombin G20210A gene mutation status, and thrombosis in patients with chronic myeloproliferative disorders
    Soyer, Nur
    Kucukarslan, Ali Sahin
    Sahin, Fahri
    Cekdemir, Demet
    Kosova, Buket
    Eroglu, Zuhal
    Tobu, Mahmut
    Tombuloglu, Murat
    Cagirgan, Seckin
    Donmez, Ayhan
    Vural, Filiz
    Saydam, Guray
    TURKISH JOURNAL OF HEMATOLOGY, 2011, 28 (04) : 306 - 311
  • [24] Factor V Leiden and prothrombin gene G20210A mutation in children with cerebral thromboembolism
    Bonduel, M
    Sciuccati, G
    Hepner, M
    Pieroni, G
    Torres, AF
    Mardaraz, C
    Frontroth, JP
    AMERICAN JOURNAL OF HEMATOLOGY, 2003, 73 (02) : 81 - 86
  • [25] Portal vein thrombosis in association with factor V Leiden mutation in a patient with hepatocellular carcinoma
    Gurgey, A
    Buyukpamukcu, M
    Baskut, C
    Yalcin, B
    Gogus, S
    MEDICAL AND PEDIATRIC ONCOLOGY, 1997, 29 (03): : 224 - 225
  • [26] Factor V Leiden and prothrombin gene G20210A mutation in children with venous thromboembolism
    Bonduel, M
    Hepner, M
    Sciuccati, G
    Pieroni, G
    Feliú-Torres, A
    Mardaraz, C
    Frontroth, JP
    THROMBOSIS AND HAEMOSTASIS, 2002, 87 (06) : 972 - 977
  • [27] Portal Vein Thrombosis Related to Factor V Leiden Mutation
    Cayir, Kerim
    Cadirei, Kenan
    Bilici, Mehmet
    Tekin, Salim Basol
    Keles, Mustafa
    Emre, Habip
    HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, 2009, 47 (04): : 181 - 182
  • [28] Lupus anticoagulant, Factor V Leiden, and methylenetetrahydrofolate reductase gene mutation in a lupus patient with cerebral venous thrombosis
    Imad Uthman
    Ismail Khalil
    Raja Sawaya
    Ali Taher
    Clinical Rheumatology, 2004, 23 : 362 - 363
  • [29] Lupus anticoagulant, Factor V Leiden, and methylenetetrahydrofolate reductase gene mutation in a lupus patient with cerebral venous thrombosis
    Uthman, I
    Khalil, I
    Sawaya, R
    Taher, A
    CLINICAL RHEUMATOLOGY, 2004, 23 (04) : 362 - 363
  • [30] Prevalence of factor V Leiden and the G20210A prothrombin-gene mutation in inflammatory bowel disease
    Papa, A
    De Stefano, V
    Gasbarrini, A
    Chiusolo, P
    Cianci, R
    Casorelli, I
    Paciaroni, K
    Cammarota, G
    Leone, G
    Gasbarrini, G
    BLOOD COAGULATION & FIBRINOLYSIS, 2000, 11 (05) : 499 - 503